• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血管活性肠肽和促甲状腺素释放激素联合应用对大鼠催乳素细胞和生长激素细胞反应的差异。

Differential response of lactotrophs and somatotrophs to a joint application of vasoactive intestinal Peptide and thyrotrophin-releasing hormone in the rat.

机构信息

Unité de Neuroendocrinologie, INSERM U 159, 2ter, rue d'Alésia, 75014 Paris, France.

出版信息

J Neuroendocrinol. 1989 Apr 1;1(2):135-9. doi: 10.1111/j.1365-2826.1989.tb00092.x.

DOI:10.1111/j.1365-2826.1989.tb00092.x
PMID:19210471
Abstract

Abstract We have studied the responses of growth hormone, prolactin and thyrotrophin to vasoactive intestinal peptide and thyrotrophin-releasing hormone added either together or separately under various in vivo (free-moving, intact animals or rats bearing hypothalamic lesions) or in vitro (perifused anterior pituitary fragments) conditions. Thyrotrophin-releasing hormone or vasoactive intestinal peptide stimulated prolactin release in all cases and the individual effects of both peptides were additive when administered together. Vasoactive intestinal peptide, but not thyrotrophin-releasing hormone, induced a growth hormone response in intact rats. In contrast, both peptides stimulated growth hormone release in lesioned rats as well as in perifused anterior pituitary fragments. In that case, the effect of vasoactive intestinal peptide on growth hormone release was not additive with that of thyrotrophin-releasing hormone, either in vivo or in vitro. Thyrotrophin release was slightly stimulated by vasoactive intestinal peptide, whereas it responded markedly to thyrotrophin-releasing hormone. The effect of thyrotrophin releasing-hormone was not further affected by simultaneous vasoactive intestinal peptide administration. These data suggest that additivity of the effect of second messengers generated as a response to thyrotrophin-releasing hormone and vasoactive intestinal peptide are specific of the target cell type.

摘要

摘要 我们研究了在不同的体内(自由活动、完整动物或下丘脑损伤的大鼠)或体外(灌流前垂体片段)条件下,血管活性肠肽和促甲状腺素释放激素同时或分别添加时对生长激素、催乳素和促甲状腺激素的反应。在所有情况下,促甲状腺素释放激素或血管活性肠肽都刺激催乳素释放,当两者同时给药时,其单独作用具有加性。血管活性肠肽而不是促甲状腺素释放激素在完整大鼠中引起生长激素反应。相反,两种肽都刺激损伤大鼠和灌流前垂体片段中的生长激素释放。在这种情况下,血管活性肠肽对生长激素释放的作用与促甲状腺素释放激素在体内或体外均无加性。血管活性肠肽略微刺激促甲状腺素释放,而它对促甲状腺素释放激素的反应明显。促甲状腺素释放激素的作用不受同时给予血管活性肠肽的影响。这些数据表明,作为对促甲状腺素释放激素和血管活性肠肽反应生成的第二信使的作用的加性是特定于靶细胞类型的。

相似文献

1
Differential response of lactotrophs and somatotrophs to a joint application of vasoactive intestinal Peptide and thyrotrophin-releasing hormone in the rat.血管活性肠肽和促甲状腺素释放激素联合应用对大鼠催乳素细胞和生长激素细胞反应的差异。
J Neuroendocrinol. 1989 Apr 1;1(2):135-9. doi: 10.1111/j.1365-2826.1989.tb00092.x.
2
Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.促甲状腺激素释放激素、血管活性肠肽、催乳素释放肽及多巴胺对大鼠不同形态学亚型泌乳细胞分泌催乳素的调节作用
J Neuroendocrinol. 2007 Aug;19(8):605-13. doi: 10.1111/j.1365-2826.2007.01567.x.
3
Stimulation and inhibition of prolactin release by prolactin-releasing Peptide in rat anterior pituitary cell aggregates.催乳素释放肽对大鼠垂体前叶细胞聚集体催乳素释放的刺激和抑制作用。
J Neuroendocrinol. 2005 Jun;17(6):379-86. doi: 10.1111/j.1365-2826.2005.01313.x.
4
Arachidonate metabolism in the anterior pituitary: effect of arachidonate inhibitors on Basal and stimulated secretion of prolactin, growth hormone and luteinizing hormone. I. Hormone release from incubated or perifused pituitary fragments.前垂体中的花生四烯酸代谢:花生四烯酸抑制剂对基础和刺激的催乳素、生长激素和黄体生成素分泌的影响。I. 孵育或灌流垂体片段中的激素释放。
J Neuroendocrinol. 1990 Aug 1;2(4):439-44. doi: 10.1111/j.1365-2826.1990.tb00430.x.
5
Pyridostigmine, an Acetylcholinesterase Inhibitor, Stimulates Growth Hormone Release, but has no Effect on Basal Thyrotrophin or Adrenocorticotrophin Levels, or the Thyrotrophin Response to Thyrotrophin-Releasing Hormone.吡啶斯的明,一种乙酰胆碱酯酶抑制剂,刺激生长激素释放,但对基础促甲状腺素或促肾上腺皮质激素水平没有影响,也不影响促甲状腺激素对促甲状腺激素释放激素的反应。
J Neuroendocrinol. 1990 Aug 1;2(4):429-32. doi: 10.1111/j.1365-2826.1990.tb00428.x.
6
Arachidonate Metabolism in the Anterior Pituitary: Effect of Arachidonate Inhibitors on Basal and Stimulated Secretion of Prolactin, Growth Hormone and Luteinizing Hormone. II. Hormone Release from Dispersed Pituitary Cells.花生四烯酸代谢在前垂体:花生四烯酸抑制剂对基础和刺激催乳素、生长激素和促黄体激素分泌的影响。二、分散垂体细胞的激素释放。
J Neuroendocrinol. 1990 Aug 1;2(4):445-52. doi: 10.1111/j.1365-2826.1990.tb00431.x.
7
Pituitary cocaine- and amphetamine-regulated transcript expression depends on the strain, sex and oestrous cycle in the rat.垂体可卡因和苯丙胺调节转录物的表达取决于大鼠的品系、性别和发情周期。
J Neuroendocrinol. 2006 Jun;18(6):426-33. doi: 10.1111/j.1365-2826.2006.01435.x.
8
Thyrotrophin-Releasing Hormone Raises Cytosolic Free Calcium Concentration in Human Adenomatous Somatotrophs and Corticotrophs; Comparison with in vivo Responsiveness to Thyrotrophin-Releasing Hormone in Patients with Acromegaly or Cushing's Disease.促甲状腺素释放激素升高人类腺瘤生长激素细胞和促皮质素细胞胞浆游离钙浓度;与肢端肥大症或库欣病患者对促甲状腺素释放激素的体内反应比较。
J Neuroendocrinol. 1991 Feb 1;3(1):51-6. doi: 10.1111/j.1365-2826.1991.tb00238.x.
9
Central administration of orexin A suppresses basal and domperidone stimulated plasma prolactin.中枢给予食欲素A可抑制基础状态及多潘立酮刺激后的血浆催乳素水平。
J Neuroendocrinol. 2000 Dec;12(12):1213-8.
10
Somatostatin and Thyrotrophin-Releasing Hormone Response and Receptor Status of a Thyrotrophin-Secreting Pituitary Adenoma: Clinical and in vitro Studies.生长抑素和促甲状腺激素释放激素反应与促甲状腺激素分泌垂体腺瘤的受体状态:临床和体外研究。
J Neuroendocrinol. 1989 Oct 1;1(5):321-6. doi: 10.1111/j.1365-2826.1989.tb00123.x.